| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/APPI.AJGP.13.6.469 |
| P698 | PubMed publication ID | 15956266 |
| P50 | author | Jeffrey L. Cummings | Q6175920 |
| P2093 | author name string | Il-Seon Shin | |
| Donna Masterman | |||
| Lynn Fairbanks | |||
| Michele Carter | |||
| P433 | issue | 6 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| quality of life | Q13100823 | ||
| P304 | page(s) | 469-474 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | American Journal of Geriatric Psychiatry | Q15752426 |
| P1476 | title | Neuropsychiatric symptoms and quality of life in Alzheimer disease. | |
| P478 | volume | 13 |
| Q92017867 | 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone |
| Q36149712 | Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease |
| Q42729410 | Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial |
| Q33654165 | Anxiety and stigma in dementia: a threat to aging in place |
| Q48717765 | Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease |
| Q33727017 | Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons |
| Q92210508 | Behavioral Disturbances in Dementia and Beyond: Time for a New Conceptual Frame? |
| Q51891838 | Behavioral and psychological symptoms of dementia in relation to level of cognitive impairment. |
| Q92584394 | Brain Perfusion Correlates of Apathy in Alzheimer's Disease |
| Q92000635 | Changes in cognition precede changes in HRQoL among HIV+ males: Longitudinal analysis of the multicenter AIDS cohort study |
| Q90587999 | Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis |
| Q36292732 | Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial |
| Q50765249 | Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control. |
| Q48681044 | Correlates of agitation and depression in nursing home residents with dementia |
| Q33649293 | Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease |
| Q46126309 | Derivation of a brief measure of agitation and aggression in Alzheimer's disease |
| Q47762578 | Distress Associated with Dementia-Related Psychosis and Agitation in Relation to Healthcare Utilization and Costs |
| Q30844521 | Elevated emotional contagion in a mouse model of Alzheimer's disease is associated with increased synchronization in the insula and amygdala |
| Q60620807 | Emotionale Kompetenz – der Einfluss von kognitiver Beeinträchtigung und Depression im Alter |
| Q24312069 | Evaluating the Cornell Scale for Depression in Dementia as a proxy measure in nursing home residents with and without dementia |
| Q44924905 | Evaluating the quality of life of people with dementia in residential care facilities |
| Q33797032 | Factor structure and invariance of the Quality of Life in Alzheimer's Disease (QoL-AD) Scale |
| Q30619452 | GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals |
| Q34035954 | Gender-dependence of substituted judgment on quality of life in patients with dementia |
| Q29417042 | Genome-wide association study of Alzheimer's disease with psychotic symptoms |
| Q42690760 | Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology |
| Q89692590 | Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing |
| Q35942354 | Impact of physical activity on activity of daily living in moderate to severe dementia: a critical review |
| Q47920988 | Instruments to measure behavioural and psychological symptoms of dementia. |
| Q92138485 | Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial |
| Q49066177 | Metabolic connectivity for differential diagnosis of dementing disorders. |
| Q37610213 | Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease |
| Q33750581 | Mindfulness-Based Cognitive Therapy (MBCT) programme for depression in people with early stages of dementia: study protocol for a randomised controlled feasibility study |
| Q37685048 | Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease |
| Q36547529 | Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. |
| Q35120545 | Neuropsychiatric symptoms in patients with dementia in primary care: a study protocol |
| Q47649710 | Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer's type |
| Q37212835 | Patient and caregiver quality of life in Huntington's disease |
| Q35804300 | Personal Strengths and Health Related Quality of Life in Dementia Caregivers from Latin America |
| Q36849968 | Pharmacotherapeutic management of dementia across settings of care |
| Q34100750 | Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study |
| Q33737223 | Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial |
| Q36063264 | Principles and management of neuropsychiatric symptoms in Alzheimer's dementia |
| Q34577786 | Psychotropic medication use for behavioral symptoms of dementia |
| Q48629607 | Quality of life among elderly patients with dementia in institutions |
| Q92021691 | Quality of life of family carers of persons with young-onset dementia: A Nordic two-year observational multicenter study |
| Q33888693 | Quality of life of residents with dementia in long-term care settings in the Netherlands and Belgium: design of a longitudinal comparative study in traditional nursing homes and small-scale living facilities |
| Q35136313 | Recalled attributes of parents with Alzheimer's disease: relevance for caregiving |
| Q36441806 | Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responses |
| Q89257629 | Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition |
| Q37407410 | Responsiveness and construct validity of the health utilities index in patients with dementia |
| Q89287870 | Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement |
| Q37973633 | Review of emotion recognition in mild cognitive impairment |
| Q92796886 | Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review |
| Q47778565 | Self-reported personality traits are prospectively associated with proxy-reported behavioral and psychological symptoms of dementia at the end of life |
| Q60044635 | Study protocol: individualized music for people with dementia - improvement of quality of life and social participation for people with dementia in institutional care |
| Q34748807 | Subcortical white matter infarcts predict 1-year outcome of fatigue in stroke |
| Q58581076 | Taking Another Look: Thoughts on Behavioral Symptoms in Dementia and Their Measurement |
| Q44825246 | The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic |
| Q89948704 | The multiplex model of the genetics of Alzheimer's disease |
| Q48407690 | The quality of life of people with dementia and their family carers |
| Q37308275 | The structure and validity of self-reported affect in mild cognitive impairment and mild Alzheimer's disease |
| Q64998056 | Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®. |
| Q34418781 | Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models |
| Q47864173 | Variables associated to quality of life among nursing home patients with dementia |
| Q53440513 | [Quality of life in mild cognitive impairment, patients with different stages of Alzheimer disease and healthy control subjects]. |
Search more.